Refolding, isolation and characterization of crystallizable human interferon-α8 expressed in Saccharomyces cerevisiae

Journal of Biotechnology

Volumn 50, Issue 1, 1996, Pages 63-73

  Di Marco, Stefania ^a   Fendrich, Gabriele ^a   Meyhack, Bernd ^a   Grütter, Markus G ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

crystallization; interferon 8; protein stability; re folding; Saccharomyces cerevisiae

Indexed keywords

BIOMEDICAL ENGINEERING; BIOTECHNOLOGY; CRYSTALLIZATION; IMMUNOLOGY;

PROTEIN STABILITY; RE-FOLDING;

INTERFERONS;

ALPHA INTERFERON;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; ELECTROPHORETIC MOBILITY; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

EID: 0030582426     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(96)01550-7     Document Type: Article

References (39)

1. Alkan, S.S., Weideli, H.J. and Schuerch, A.R. (1983) In: Monoclonal antibodies against human leukocyte interferons for a definition of subclasses and their affinity purification. H. Peeters (Ed.). Protides of Biological Fluids. Oxford: Pergamon Press, Oxford, pp. 495-498.
2. Brange, J. (1992) Chemical stability of insulin 4. Mechanisms and kinetics of chemical transformation in pharmaceutical formulation. Acta Pharm. Nord. 4, 209-222.
3. Carter, C.W. Jr. and Carter, C.W. (1979) Protein crystallization using incomplete factorial experiments. J. Biol. Chem. 254, 12219-12223.
4. Darby, N.J. and Creighton, T.E. (1993) Protein Structure. Oxford University Press, Oxford, UK.
5. De Maeyer, E. and De Maeyer-Guignard, J. (1988) Interferons and Other Regulatory Cytokines. Wiley, New York.
6. Di Marco, S., Grütter, M.G. Priestle, J.P. and Horisberger, M.A. (1994) Biochem. Biophys. Res. Commun. 202, 1445-1451.
7. Felix, A.M., Heimer, E.P., Lambros, T.J., Swistok, J., Tarnowski, S.J. and Wang, C.-T. (1985) Analysis of different forms of recombinant human leukocyte interferons and synthetic fragments by high-performance liquid chromatography. J. Chromatogr. 327, 359-368.
8. Fidler, I.J., Heicappell, R., Saiki, I., Grütter, M., Horisberger, M. and Nuesch, J. (1987) Direct antiproliferative effects of recombinant human interferon-α B/D hybrids on human tumor cell lines. Cancer Res. 47, 2020-2027.
9. Greiner, J.W., Fisher, P.B., Pestka, S. and Schlom, J. (1986) Differential effects of recombinant human leukocyte interferons on cell surface antigen expression. Cancer Res. 46. 4984-4990.
10. Haguenauer-Tsapis, R. and Hinnen, A. (1984) A deletion that includes the signal peptidase cleavage site impairs processing, glycosylation, and secretion of cell surface yeast acid phosphatase. Mol. Cell. Biol. 4, 2668-2675.
11. Hinnen, A., Meyhack, B. and Heim, J. (1989) Heterologous gene expression in yeast. In: P.J. Barr, A.J. Brake, and P.L. Valenzuela (Eds.), Yeast Genetic Engineering. Butterworth, Stoneham, UK, pp. 193-213.
12. Hitzeman, R.A., Hagie, F.E., Levine, H.L., Goeddel, D.V., Ammerer, G. and Hall, B.D. (1981) Expression of a human gene for interferon in yeast. Nature 293, 717-722.
13. Hochuli, R. (1986) Large-scale recovery of interferon α-2a synthesized in bacteria. Chimia 40, 408-412.
14. Horisberger, M.A. and Di Marco, S. (1995) Interferon-alpha hybrids. Pharm. Ther. 66, 507-534.
15. ISICR 1995, Clinical Highlights (1996) Purification is key. In: S. Hames (Ed.), ISICR Clinical Highlights, Colwood Houses, UK, pp. 8.
16. Korn, A.P., Rose, D.R. and Fish, E.N. (1994) Three-dimensional model of a human interferon-α consensus sequence. J. Interferon Res. 14, 1-9.
17. Laemmli, U.K. (1970) Cleavage of the structural proteins during assembly of the head of the bacteriophage T4, Nature 227, 680-685.
18. Li B.L., Zhao, X.X., Liu, X.Y., Kim, H.S., Raska, K., Ortaldo, J.R., Schwartz, B. and Pestka, S. (1990) Interferon structure and natural killer stimulatory activity. Cancer Res. 50, 5328-5332.
19. Marston, F.A.O. (1986) The purification of eukaryotic polypeptides synthesized in Escherichia coli. Biochem. J. 240, 1-12.
20. McPherson, A. (1982) Preparation and Analysis of Protein Crystals. Wiley, New York.
21. Meister, A., Uzé, G., Mogensen, K.E., Gresser, I., Tovey, M.G., Grütter, M. and Meyer, F. (1986) Biological activities and receptor binding of two human recombinant interferons and their hybrids. J. Gen. Virol. 67, 1633-1643.
22. Mitsui, Y., Senda, T., Shimazu, T., Matsuda, S. and Utsumi, J. (1993) Structural, functional and evolutionary implications of the three-dimensional crystal structure of murine interferon-β. Pharm. Ther. 58, 93-132.
23. Murgolo, N.J., Windsor, W.T., Hruza, A., Reichert, P., Tsarbopoulos, A., Baldwin, S., Huang, E., Pramanik, B., Ealick, S. and Trotta, P.P. (1993) A homology model of human interferon α-2. Proteins: Struct. Funct. Genet. 17, 62-74.
24. Nagata, S., Taira, H., Hall, A., Johnsrud, L., Streuli, M., Ersödi, J., Boll, W., Cantell, K. and Weissmann C. (1980) Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature 284, 316-320.
25. Ohara, O. and Teraoka, H. (1987) Anomalous behavior of human leukocyte interferon subtypes on polyacrylamide gel electrophoresis in the presence of dodecyl sulfate. FEBS Lett. 211, 78-82.
26. Ortaldo, J.R., Herberman, R.B., Harvey, C., Osheroff, P., Pan, Y.C., Kelder, B. and Pestka, S. (1984) A species of human α interferon that lacks the ability to boost human natural killer activity. Proc. Natl. Acad. Sci. USA 81, 4926-4929.
27. Pestka, S. (1986) Interferon from 1981 to 1986. Methods Enzymol. 119, 3-14.
28. Pestka, S., Kelder, B., Tarnowski, D,K. and Tarnowski, S.J. (1983) Specific immunoassay for protein dimers, trimers, and higher oligomers. Anal. Biochem. 132, 328-333.
29. Rehberg, E., Kelder B., Hoal, E.G. and Pestka, S. (1982) Specific molecular activities of recombinant and hybrid leucocyte interferons. J. Biol. Chem. 257, 11497-11502.
30. Rubinstein, S., Familletti, P.C. and Pestka, S. (1981) Convenient assay for interferon. J. Virol. 37, 755-758.
31. Sedmark, J.J., Jameson, P. and Grossberg, S.E. (1981) Procedures for stabilization of interferons. Methods Enzymol. 78, 591-595.
32. Sen, G.S., Herz, R., Davatelis, V. and Pestka, S. (1984) Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids. J. Virol. 50, 445-450.
33. Senda, T., Shimazu, T., Matsuda, S., Kawano, G., Shimizu, H., Nakamura, K.T. and Mitsui, Y. (1992) Three-dimensional crystal structure of recombinant murine interferon-β. EMBO J. 11, 3193-3201.
34. Smith, R.D, Loo, J.A., Edmonds, C.G., Barinaga, C.G. and Udseth, H.R. (1990) New developments in biochemical mass spectrometry: electrospray ionization. Anal. Chem. 62, 882-899.
35. Staehelin, T., Hobbs, D.S., Kung, H.-fu, Lai, C.-Y. and Pestka, S. (1981) Purification and characterization of recombinant human leukocyte interferon (IFLrA) with monoclonal antibodies. J. Biol. Chem. 256, 9750-9754.
36. Tuite, M.F., Dobson, M.J., Roberts, N.A., King, R.M., Burke, D.C., Kingsman, S.M. and Kingsman, A.J. (1982) Regulated high efficiency expression of human interferon-alpha in Saccharomyces cerevisiae. EMBO J. 1, 603-608.
37. Tutwiler, G.F. (1981) Insulin and other antidiabetic agents. In: Kirk-Othmer (Ed.), Encyclopedia of chemical technology. Wiley, New York, 3rd edn. 13, pp. 605-620.
38. Wetzel, R. (1981) Assignment of the disulfide bonds of leukocyte interferon. Nature 289, 606-607.
39. Yanagisawa, K. (1992) A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal. Hokkaido-Igaku-Zasshi 67, 81-88.